Get the Stockscreener App
2.14
3.17%
-0.07
Cardiol Therapeutics Inc Stock (CRDL) Forecast
The Cardiol Therapeutics Inc (CRDL) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.5516, representing a -27.50% decrease from the current price of $2.14. The highest analyst price target is $1.7688, and the lowest is $1.3344.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CRDL Price Target
Average 1.1133
(-47.98% Downside)
Is Cardiol Therapeutics Inc (CRDL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.04 | Neutral |
| STOCH(9,6) | 81.65 | Sell |
| STOCHRSI(14) | 72.36 | Neutral |
| MACD(12,26) | 0.0968 | Buy |
| ADX(14) | 26.73 | Buy |
| William %R | -18.18 | Sell |
| CCI(14) | 126.67 | Buy |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.016
Buy
|
2.0231
Buy
|
| MA20 |
1.8925
Buy
|
1.9431
Buy
|
| MA50 |
1.7753
Buy
|
1.7743
Buy
|
| MA100 |
1.4667
Buy
|
1.5523
Buy
|
| MA200 |
1.1904
Buy
|
1.2794
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, CRDL could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 2 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on CRDL, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 62.04 indicates that CRDL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 81.65 indicates that CRDL is oversold. This means that CRDL price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 72.36 indicates that CRDL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.73 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 126.67 indicates that CRDL is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term CRDL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cardiol Therapeutics Inc financial reports and earnings history, Cardiol Therapeutics Inc (CRDL) stock could reach $1.2858 by 2030, $2.1202 by 2040 and $2.0634 by 2050. See the projected annual prices until 2050 of the Cardiol Therapeutics Inc stock below:
- Cardiol Therapeutics Inc (CRDL) is expected to reach an average price of $0.7438 in 2035, with a high prediction of $0.7178 and a low estimate of $0.6963. This indicates an $-65.24% rise from the last recorded price of $2.14.
- Cardiol Therapeutics Inc (CRDL) stock is projected to chart a bullish course in 2040, with an average price target of $2.0451, representing an $-4.44% surge from its current level. The forecast ranges from a conservative $2.0403 to a sky-high $2.1202.
- Our analysts predict Cardiol Therapeutics Inc (CRDL) to jump 20.76% by 2045, soaring from $2.2394 to an average price of $2.5843, potentially reaching $2.5243. While $2.2394 is the low estimate, the potential upside is significant.
- Cardiol Therapeutics Inc (CRDL) stock is expected to climb by 2050, reaching an average of $2.1278, a $-0.57% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.0634 and $1.7746, respectively, highlighting the market's uncertainty.
Cardiol Therapeutics Inc Stock (CRDL) Year by Year Forecast
Cardiol Therapeutics Inc Stock (CRDL) Price Forecast for 2024
Our forecast for CRDL stock price in 2024 now indicates an average price target of $1.9314 with a high forecast of $3.3333 and a low forecast of $0.5295. The average prediction reflects an decrease of -9.75% from the last recorded price of $2.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $1.5244 | $1.3344 | $1.7688 | -28.77% |
| July, 2024 | $1.3375 | $1.0669 | $1.8775 | -37.50% |
| August, 2024 | $1.20 | $1.1482 | $1.4581 | -43.92% |
| September, 2024 | $1.0526 | $0.8513 | $1.3425 | -50.82% |
| October, 2024 | $0.9657 | $0.7538 | $1.1513 | -54.87% |
| November, 2024 | $0.8982 | $0.8482 | $1.6069 | -58.03% |
| December, 2024 | $0.8007 | $0.5295 | $0.9488 | -62.58% |
Cardiol Therapeutics Inc Stock (CRDL) Price Forecast for 2025
Cardiol Therapeutics Inc Stock (CRDL) is expected to reach an average price of $0.6239 in 2025, with a high prediction of $1.2345 and a low estimate of $0.0134. This indicates an -70.84% fall from the last recorded price of $2.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.0139 | $0.7559 | $1.1926 | -52.62% |
| February, 2025 | $0.7864 | $0.696 | $1.2345 | -63.25% |
| March, 2025 | $0.7889 | $0.6489 | $0.9876 | -63.14% |
| April, 2025 | $0.692 | $0.5901 | $0.8395 | -67.66% |
| May, 2025 | $0.3861 | $0.349 | $0.8826 | -81.96% |
| June, 2025 | $0.1458 | $0.0559 | $0.3868 | -93.19% |
| July, 2025 | $0.0655 | $0.0292 | $0.2602 | -96.94% |
| August, 2025 | $0.0827 | $0.0248 | $0.402 | -96.13% |
| September, 2025 | $0.275 | $0.0533 | $0.3644 | -87.15% |
| October, 2025 | $0.0753 | $0.0753 | $0.3069 | -96.48% |
| November, 2025 | $0.0621 | $0.0508 | $0.1389 | -97.10% |
| December, 2025 | $0.0815 | $0.0134 | $0.224 | -96.19% |
Cardiol Therapeutics Inc Stock (CRDL) Price Forecast for 2026
The predicted value for Cardiol Therapeutics Inc (CRDL) in 2026 is set at an average of $0.9162. Estimates vary from a peak of $1.7566 to a trough of $0.0758, indicating an -57.19% surge from the present price of $2.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.1217 | $0.0758 | $0.3152 | -94.31% |
| February, 2026 | $0.2371 | $0.1171 | $0.2777 | -88.92% |
| March, 2026 | $0.4615 | $0.2296 | $0.6209 | -78.43% |
| April, 2026 | $0.6547 | $0.3229 | $0.6947 | -69.41% |
| May, 2026 | $0.5657 | $0.4605 | $0.8106 | -73.57% |
| June, 2026 | $0.5547 | $0.4583 | $0.6878 | -74.08% |
| July, 2026 | $0.2728 | $0.2628 | $0.6503 | -87.25% |
| August, 2026 | $0.3452 | $0.2444 | $0.4553 | -83.87% |
| September, 2026 | $0.5587 | $0.331 | $0.6085 | -73.89% |
| October, 2026 | $0.4962 | $0.3809 | $0.5841 | -76.81% |
| November, 2026 | $0.8135 | $0.4696 | $1.0235 | -61.99% |
| December, 2026 | $1.6566 | $0.5549 | $1.7566 | -22.59% |
Cardiol Therapeutics Inc Stock (CRDL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cardiol Therapeutics Inc (CRDL) is $1.4511, with a high forecast of $2.8433 and a low forecast of $0.0589. This indicates an -32.19% decrease from the last price of $2.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0791 | $0.9485 | $1.7673 | -49.57% |
| February, 2027 | $1.3716 | $1.0298 | $1.6704 | -35.90% |
| March, 2027 | $1.4113 | $1.2923 | $2.8433 | -34.05% |
| April, 2027 | $0.9963 | $0.8763 | $1.4525 | -53.44% |
| May, 2027 | $0.8813 | $0.7813 | $1.2825 | -58.82% |
| June, 2027 | $0.8876 | $0.5838 | $1.3951 | -58.52% |
| July, 2027 | $0.6126 | $0.3726 | $0.9487 | -71.37% |
| August, 2027 | $0.5776 | $0.2776 | $0.865 | -73.01% |
| September, 2027 | $1.1039 | $0.3501 | $1.1339 | -48.42% |
| October, 2027 | $0.2389 | $0.0589 | $1.0952 | -88.84% |
| November, 2027 | $0.3839 | $0.1102 | $0.4427 | -82.06% |
| December, 2027 | $0.4102 | $0.3265 | $0.769 | -80.83% |
Cardiol Therapeutics Inc Stock (CRDL) Price Forecast for 2028
In 2028, Cardiol Therapeutics Inc (CRDL) is projected to reach an average price of $0.3051, with a high projection of $0.5252 and a low estimate of $0.0849. This indicates an -85.74% fall from the last price of $2.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.3952 | $0.2323 | $0.5252 | -81.53% |
| February, 2028 | $0.1603 | $0.1303 | $0.513 | -92.51% |
| March, 2028 | $0.1865 | $0.1065 | $0.4253 | -91.28% |
| April, 2028 | $0.3685 | $0.0849 | $0.2578 | -82.78% |
| May, 2028 | $0.3767 | $0.3217 | $0.3034 | -82.40% |
| June, 2028 | $0.1821 | $0.3909 | $0.3697 | -91.49% |
| July, 2028 | $0.2608 | $0.2485 | $0.3335 | -87.81% |
| August, 2028 | $0.1774 | $0.2058 | $0.1573 | -91.71% |
| September, 2028 | $0.3504 | $0.2946 | $0.3058 | -83.63% |
| October, 2028 | $0.3747 | $0.3756 | $0.3537 | -82.49% |
| November, 2028 | $0.2499 | $0.3072 | $0.3654 | -88.32% |
| December, 2028 | $0.1906 | $0.2743 | $0.2321 | -91.09% |
Cardiol Therapeutics Inc Stock (CRDL) Price Forecast for 2029
The 2029 price forecast for Cardiol Therapeutics Inc Stock (CRDL) is $0.6826 on average, with a high prediction of $1.3645 and a low estimate of $0.00065. This represents an -68.10% decrease from the previous price of $2.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0267 | $0.0474 | $0.1918 | -98.75% |
| February, 2029 | $0.0239 | $0.0657 | $0.0883 | -98.88% |
| March, 2029 | $0.0718 | $0.0119 | $0.3859 | -96.64% |
| April, 2029 | $0.1568 | $0.0371 | $0.2656 | -92.67% |
| May, 2029 | $0.0131 | $0.0319 | $0.2306 | -99.39% |
| June, 2029 | $0.00186 | $0.0319 | $0.2044 | -99.91% |
| July, 2029 | $0.0332 | $0.0168 | $0.0631 | -98.45% |
| August, 2029 | $0.0144 | $0.0294 | $0.1969 | -99.33% |
| September, 2029 | $0.2545 | $0.00065 | $0.2845 | -88.11% |
| October, 2029 | $0.6207 | $0.1502 | $0.6707 | -70.99% |
| November, 2029 | $0.6958 | $0.6358 | $1.3645 | -67.49% |
| December, 2029 | $1.1008 | $0.547 | $1.2708 | -48.56% |
Cardiol Therapeutics Inc Stock (CRDL) Price Forecast for 2030
Cardiol Therapeutics Inc Stock (CRDL) is expected to reach an average price of $1.1852 in 2030, with a high forecast of $2.3533 and a low forecast of $0.0171. This signifies an -44.62% decrease from the last price of $2.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.0195 | $0.7533 | $1.2858 | -52.36% |
| February, 2030 | $0.6956 | $0.5256 | $2.3533 | -67.49% |
| March, 2030 | $0.5532 | $0.3632 | $0.7963 | -74.15% |
| April, 2030 | $0.5507 | $0.1007 | $0.6451 | -74.27% |
| May, 2030 | $0.2401 | $0.1845 | $0.9126 | -88.78% |
| June, 2030 | $0.0977 | $0.0658 | $0.3876 | -95.44% |
| July, 2030 | $0.0171 | $0.0171 | $0.1989 | -99.20% |
| August, 2030 | $0.0454 | $0.019 | $0.6608 | -97.88% |
| September, 2030 | $0.1379 | $0.1735 | $0.1716 | -93.56% |
| October, 2030 | $0.0816 | $0.0821 | $0.2578 | -96.19% |
| November, 2030 | $0.1409 | $0.093 | $0.3034 | -93.42% |
| December, 2030 | $0.1334 | $0.0853 | $0.0629 | -93.77% |
0.92%
Cap:
|
Volume (24h):